Functional Fitness — Normative Values of Functional Fitness in Elderly Population
Citation(s)
Chen B, Shin S Bibliometric Analysis on Research Trend of Accidental Falls in Older Adults by Using Citespace-Focused on Web of Science Core Collection (2010-2020). Int J Environ Res Public Health. 2021 Feb 9;18(4). pii: 1663. doi: 10.3390/ijerph18041663.
Clark PG, Blissmer BJ, Greene GW, Lees FD, Riebe DA, Stamm KE Maintaining exercise and healthful eating in older adults: the SENIOR project II: study design and methodology. Contemp Clin Trials. 2011 Jan;32(1):129-39. doi: 10.1016/j.cct.2010.10.002. Epub 2010 Oct 16.
Naz L, Ghimire U, Zainab A Behavioral factors associated with utilization of healthcare services among elderly in Pakistan: evidence from a nationally representative survey. BMC Geriatr. 2021 Jan 12;21(1):42. doi: 10.1186/s12877-021-02005-3.
Ortega FB, Cadenas-Sanchez C, Lee DC, Ruiz JR, Blair SN, Sui X Fitness and Fatness as Health Markers through the Lifespan: An Overview of Current Knowledge. Prog Prev Med (N Y). 2018 Apr 2;3(2):e0013. doi: 10.1097/pp9.0000000000000013. eCollection 2018 Apr.
Sabzwari SR, Iqbal R, Fatmi Z, Azam I Factors associated with geriatric morbidity and impairment in a megacity of Pakistan. PLoS One. 2019 Jun 27;14(6):e0218872. doi: 10.1371/journal.pone.0218872. eCollection 2019.
Normative Values of Functional Fitness in Elderly Population
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
